Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 35
Selected: 0
NCT IDTitle
NCT03036865Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of BOS161721 in Healthy Subjects
NCT00917826Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
NCT03328494Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies
NCT02053480Pyruvate Kinase Deficiency Natural History Study
NCT02462889IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD
NCT00433186Mycophenolate Mofetil in Systemic Sclerosis
NCT01642758Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon
NCT03694158Investigating Dupilumab's Effect in Asthma by Genotype
NCT04163263Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris
NCT01192672Use of Expressive Writing in Irritable Bowel Syndrome (IBS)
NCT03828201Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
NCT00306969Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
NCT04221906Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test
NCT03780517Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors
NCT03464058Study to Determine the Single and Repeat Dose Pharmacokinetics, Food Effect, Proton Pump Inhibitor (PPI) Drug Interaction, Safety and Tolerability of Oral Prototype Formulations of BOS172767 in Healthy Subjects
NCT01538719IL1-TRAP, Rilonacept, in Systemic Sclerosis
NCT03977155Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
NCT03960450Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis
NCT01289912Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
NCT01813500Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
NCT01083316Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
NCT02994784Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients
NCT00677508Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
NCT01090921Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma
NCT04880031A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension
NCT04514237Study to Determine the Relative Bioavailability, Single and Repeat Dose Pharmacokinetics, Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects
NCT02991807RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome
NCT03723954Heart Rate Variations of Golf Fans During the 2018 the Ryder Cup
NCT01724554Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
NCT03371251Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care
NCT02841033Daratumumab for the Treatment of Patients With AL Amyloidosis
NCT01966328A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment
NCT05637697Angelman Syndrome Video Assessment (ASVA) Source Material Study
NCT04257383The Sugira Muryango PLAY Collaborative
NCT01918397Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB